Antimicrob Agents Chemother

1. KENGO A, Nabeemeeah F, Denti P, Sabet R, et al
   Assessing potential drug-drug interactions between clofazimine and other frequently used agents to treat drug-resistant tuberculosis.
   Antimicrob Agents Chemother. 2024 Apr 10:e0158323. doi: 10.1128/aac.01583.
   

   >> Share

   
   
2. LOSSOUARN J, Beurrier E, Bouteau A, Moncaut E, et al
   The virtue of training: extending phage host spectra against vancomycin-resistant Enterococcus faecium strains using the Appelmans method.
   Antimicrob Agents Chemother. 2024 Apr 9:e0143923. doi: 10.1128/aac.01439.
   

   >> Share

   
   
3. POONAWALA H, Zhang Y, Kuchibhotla S, Green AG, et al
   Transcriptomic responses to antibiotic exposure in Mycobacterium tuberculosis.
   Antimicrob Agents Chemother. 2024 Apr 8:e0118523. doi: 10.1128/aac.01185.
   

   >> Share

   
   

   
   Clin Infect Dis

4. YANG E, Sajhwani D, Fassnacht R, Mehta L, et al
   High rates of acquisition of toxigenic Clostridioides difficile colonization without subsequent infection during acute lymphoblastic leukemia treatment in children.
   Clin Infect Dis. 2023 Oct 11:ciad628. doi: 10.1093.
   

   >> Share

   
   
5. STRAUB TJ, Lombardo MJ, Bryant JA, Diao L, et al
   Impact of a purified microbiome therapeutic on abundance of antimicrobial resistance genes in patients with recurrent Clostridioides difficile infection.
   Clin Infect Dis. 2023 Oct 12:ciad636. doi: 10.1093.
   

   >> Share

   
   
6. QIU J, Zimmet AN, Bell TD, Gadrey S, et al
   Pathophysiological Responses to Bloodstream Infection in Critically Ill Transplant Recipients Compared With Non-Transplant Recipients.
   Clin Infect Dis. 2024;78:1011-1021.
   

   >> Share

   
   
7. UJIIE M
   Tetanus Toxoid Antibody Seroprevalence in Japan.
   Clin Infect Dis. 2024;78:1079-1080.
   

   >> Share

   
   
8. MIKIASHVILI L, Kempker RR, Chakhaia TS, Bablishvili N, et al
   Impact of Prior Tuberculosis Treatment With New/Companion Drugs on Clinical Outcomes in Patients Receiving Concomitant Bedaquiline and Delamanid for Multidrug- and Rifampicin-Resistant Tuberculosis.
   Clin Infect Dis. 2024;78:1043-1052.
   

   >> Share

   
   
9. MARINER-LLICER C, Saavedra Cervera B, Mambuque E, Gomes N, et al
   Monitoring of First-line Drug Resistance Mutations Outside the Scope of Xpert MTB/RIF Ultra is Needed for Successful Control of DR-TB in Southern Mozambique.
   Clin Infect Dis. 2024;78:842-845.
   

   >> Share

   
   
10. RYBAK A, Assad Z, Levy C, Bonarcorsi S, et al
    Age-specific resurgence in invasive pneumococcal disease incidence in the COVID-19 pandemic era and its association with respiratory virus and pneumococcal carriage dynamics: a time series analysis.
    Clin Infect Dis. 2023 Dec 6:ciad746. doi: 10.1093.
    

    >> Share

    
    
11. CHABALA C, Wobudeya E, van der Zalm MM, Kapasa M, et al
    Clinical outcomes in children living with HIV treated for non-severe tuberculosis in the SHINE Trial.
    Clin Infect Dis. 2024 Apr 9:ciae193. doi: 10.1093.
    

    >> Share

    
    
12. CHASTAIN DB, Spradlin M, Ahmad H, Henao-Martinez AF, et al
    Executive Summary: State-of-the-Art Review: Unintended Consequences: Risk of Opportunistic Infections Associated with Long-term Glucocorticoid Therapies in Adults.
    Clin Infect Dis. 2024;78:811-812.
    

    >> Share

    
    

    
    Diagn Microbiol Infect Dis

13. LI W, Huang Y, Tong S, Wan C, et al
    The characteristics of the gut microbiota in patients with pulmonary tuberculosis: A systematic review.
    Diagn Microbiol Infect Dis. 2024;109:116291.
    

    >> Share

    
    

    
    Eur J Clin Microbiol Infect Dis

14. CAMPBELL S, Smith S, Hanson J
    Lincosamide monotherapy treatment of methicillin-resistant Staphylococcus aureus pneumonia in tropical Australia: a case series.
    Eur J Clin Microbiol Infect Dis. 2024 Apr 12. doi: 10.1007/s10096-024-04816.
    

    >> Share

    
    

    
    Infect Immun

15. WILLIAMS MT, Zhang Y, Pulse ME, Berg RE, et al
    Suppression of host humoral immunity by Borrelia burgdorferi varies over the course of infection.
    Infect Immun. 2024;92:e0001824.
    

    >> Share

    
    
16. VANCE DJ, Basir S, Piazza CL, Willsey GG, et al
    Single-domain antibodies reveal unique borrelicidal epitopes on the Lyme disease vaccine antigen, outer surface protein A (OspA).
    Infect Immun. 2024 Mar 12:e0008424. doi: 10.1128/iai.00084.
    

    >> Share

    
    

    
    J Antimicrob Chemother

17. STEMKENS R, Mouhdad C, Franssen EJF, Touw D, et al
    Ten-year results of an international external quality control programme for measurement of anti-tuberculosis drug concentrations.
    J Antimicrob Chemother. 2024 Apr 6:dkae105. doi: 10.1093.
    

    >> Share

    
    

    
    J Biol Chem

18. SHEARER HL, Currie MJ, Agnew HN, Trappetti C, et al
    Hypothiocyanous acid reductase is critical for host colonization and infection by Streptococcus pneumoniae.
    J Biol Chem. 2024 Apr 9:107282. doi: 10.1016/j.jbc.2024.107282.
    

    >> Share

    
    

    
    J Clin Microbiol

19. PENG Y, Williams MM, Xiaoli L, Simon A, et al
    Strengthening Bordetella pertussis genomic surveillance by direct sequencing of residual positive specimens.
    J Clin Microbiol. 2024;62:e0165323.
    

    >> Share

    
    
20. WALSH TJ, Mencacci A, Paggi R, Douka E, et al
    Prospective observational pilot study of the T2Resistance panel in the T2Dx system for detection of resistance genes in bacterial bloodstream infections.
    J Clin Microbiol. 2024;62:e0129623.
    

    >> Share

    
    
21. GHANEM-ZOUBI N, Mustafa-Hellou M, Zahran M, Gazit L, et al
    The integration of Coxiella burnetii PCR testing in serum into the diagnostic algorithm of suspected acute Q fever in an endemic setting.
    J Clin Microbiol. 2024;62:e0170323.
    

    >> Share

    
    
22. GIFFEN SR, Stoeppler E, Elliott A, Miller MB, et al
    Evaluation of analyte-specific reagents for the direct detection of Pneumocystis jirovecii.
    J Clin Microbiol. 2024;62:e0004524.
    

    >> Share

    
    
23. ITO A, Ishida T, Tachibana H, Nakanishi Y, et al
    Identification rate of Legionella species in non-purulent sputum culture is comparable to that in purulent sputum culture in Legionella pneumonia.
    J Clin Microbiol. 2024;62:e0166523.
    

    >> Share

    
    
24. WEEBER P, Singh N, Lapierre P, Mingle L, et al
    A novel hybridization capture method for direct whole genome sequencing of clinical specimens to inform Legionnaires' disease investigations.
    J Clin Microbiol. 2024;62:e0130523.
    

    >> Share

    
    
25. STREVA VA, Weinstein J, Jankowski-Romano C, Osakwe N, et al
    The Brief Case: Incidental finding of Brucella abortus bacteremia in a patient with urinary tract infection.
    J Clin Microbiol. 2024;62:e0138123.
    

    >> Share

    
    
26. MORENO A, Mah J, Budvytiene I, Ho DY, et al
    Dynamics and prognostic value of plasma cell-free DNA PCR in patients with invasive aspergillosis and mucormycosis.
    J Clin Microbiol. 2024 Apr 11:e0039424. doi: 10.1128/jcm.00394.
    

    >> Share

    
    

    
    J Med Microbiol

27. AGUILERA-FRANCO M, Tarrino-Leon M, Olivares-Duran MJ, Espadafor B, et al
    Evaluation of a new CT/NG/TV/MG Real-Time PCR Kit (Vircell) versus the Allplex STI Essential Assay (Seegene) for the diagnosis of sexually transmitted infections.
    J Med Microbiol. 2024;73.
    

    >> Share

    
    

    
    JAMA

28. ANDERER S
    Meta-Analysis: Females at Higher Risk of Death From Staph Infection.
    JAMA. 2024;331:1172.
    

    >> Share

    
    

    
    N Engl J Med

29. STAFFORD IA, Workowski KA, Bachmann LH
    Syphilis Complicating Pregnancy and Congenital Syphilis. Reply.
    N Engl J Med. 2024;390:1251.
    

    >> Share

    
    
30. SANDOVAL C
    Syphilis Complicating Pregnancy and Congenital Syphilis.
    N Engl J Med. 2024;390:1251.
    

    >> Share

    
    

    
    Nature

31. WU Q, Zhang J, Kumar S, Shen S, et al
    Resilient anatomy and local plasticity of naive and stress haematopoiesis.
    Nature. 2024;627:839-846.
    

    >> Share

    
    

    
    PLoS Negl Trop Dis

32. SAEZ-LOPEZ E, Millan-Placer AC, Lucia A, Ramon-Garcia S, et al
    Amoxicillin/clavulanate in combination with rifampicin/clarithromycin is bactericidal against Mycobacterium ulcerans.
    PLoS Negl Trop Dis. 2024;18:e0011867.
    

    >> Share

    
    

    
    PLoS One

33. OMONGOT S, Muttamba W, Najjingo I, Baruch Baluku J, et al
    Strategies to resolve the gap in adolescent tuberculosis care at four health facilities in Uganda: The teenager's TB pilot project.
    PLoS One. 2024;19:e0286894.
    

    >> Share

    
    
34. OU J, Li J, Liu Y, Su X, et al
    Quality appraisal of clinical guidelines for Helicobacter pylori infection and systematic analysis of the level of evidence for recommendations.
    PLoS One. 2024;19:e0301006.
    

    >> Share

    
    
35. GARCIA-LOPEZ M, Lurier T, Bouilloud M, Pradel J, et al
    Prevalence, genetic diversity and eco-epidemiology of pathogenic Leptospira species in small mammal communities in urban parks Lyon city, France.
    PLoS One. 2024;19:e0300523.
    

    >> Share

    
    
36. TETTEH FKM, Ablordey A, Obeng-Nkrumah N, Opintan JA, et al
    Extended-spectrum beta-lactamases in clinical isolates of Escherichia coli and Klebsiella pneumoniae recovered from patients at the Tamale Teaching Hospital, Ghana.
    PLoS One. 2024;19:e0300596.
    

    >> Share

    
    
37. GAO Y, Yang XJ, Zhu Y, Yang M, et al
    Association between rosacea and helicobacter pylori infection: A meta-analysis.
    PLoS One. 2024;19:e0301703.
    

    >> Share

    
    
38. SINGHA S, Koop G, Rahman MM, Ceciliani F, et al
    Pathogen group-specific risk factors for intramammary infection in water buffalo.
    PLoS One. 2024;19:e0299929.
    

    >> Share

    
    

    
    PLoS Pathog

39. BOBBA S, Chauhan KS, Akter S, Das S, et al
    A protective role for type I interferon signaling following infection with Mycobacterium tuberculosis carrying the rifampicin drug resistance-conferring RpoB mutation H445Y.
    PLoS Pathog. 2024;20:e1012137.
    

    >> Share

    
    
40. GNAIEN M, Maufrais C, Rebai Y, Kallel A, et al
    A gain-of-function mutation in zinc cluster transcription factor Rob1 Drives Candida albicans adaptive growth in the cystic fibrosis lung environment.
    PLoS Pathog. 2024;20:e1012154.
    

    >> Share

    
    
41. FULLER NM, McQuaid CF, Harker MJ, Weerasuriya CK, et al
    Mathematical models of drug-resistant tuberculosis lack bacterial heterogeneity: A systematic review.
    PLoS Pathog. 2024;20:e1011574.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share